For most, Christmas Day is synonymous with indulgent feasting, often leading to a calorie intake far exceeding daily recommendations. However, for wellness enthusiasts, particularly biohackers and the 40 million Americans using GLP-1 weight-loss medications like Ozempic or Mounjaro, holiday eating requires a meticulously planned approach. These individuals must exercise caution, as GLP-1 drugs significantly reduce appetite and slow stomach emptying, making overindulgence a risk factor for severe nausea, vomiting, and even life-threatening intestinal blockages.

Daily Mail investigated how two distinct groups, a biohacker and a weight-loss drug user, navigate Christmas Day meals while adhering to their specific lifestyles. While both acknowledged making room for traditional favorites like mashed potatoes and desserts, a common thread was their deliberate avoidance of alcohol. The average person's Christmas Day gluttony, consuming an estimated 5,370 calories, would take nearly nine days of non-stop walking to burn off – a stark contrast to the mindful eating practices of these groups.

Amie Hornaman, a 51-year-old doctor of clinical nutrition and avid biohacker, exemplifies a restrained approach to holiday feasting. With a biological age of 42, Hornaman, who promotes a lifestyle for improved thyroid, hormonal, and metabolic health, has moved past her body-building days of unrestricted eating. Instead of alcohol, she enjoys a mushroom nootropic infused with THC and CBD, claiming it provides an 'alcohol-like buzz' without the associated health downsides like poor sleep or increased risk of depression. Her main meal consists of traditional turkey, fish, steak, sweet potatoes, and roasted Brussel sprouts, though she prioritizes meat, filling most of her plate due to concerns about some vegetables raising inflammation levels. She also strategically eats her protein first, a practice supported by studies showing reduced blood sugar spikes and improved digestion. For dessert, a few cookies suffice, a controlled indulgence aided by her weekly microdosing of tirzepatide, a weight-loss drug, at doses between 0.5 and 1.5 milligrams. This microdosing allows her to enjoy holiday foods without overdoing it or experiencing disordered eating.

Sarah-Marie Cole, a 44-year-old GLP-1 user, has been on weight-loss medication for nearly three years. After gaining 100lbs in her mid-20s and finding no success with various diets, she began Mounjaro (active drug tirzepatide) in late 2023, later switching to Zepbound. Having lost 109lbs, she has developed a sophisticated strategy for Christmas feasting. Her main meal involves a small salad bowl filled half with roast beef tenderloin and the other half with mashed potatoes, butternut squash, green beans, and Brussel sprouts, all in controlled portions. For dessert, she enjoys small slivers of pumpkin pie, pecan pie, cheesecake, and a homemade cookie. Cole, currently on 12.5 milligrams of Zepbound weekly, echoes Hornaman's stance on alcohol, opting for a few sips of red wine at most, preferring CBD-infused beverages and non-super-sweet mocktails to 'be part of the party.' She emphasizes that on weight-loss drugs, one can still enjoy everything in very small portions, as the medication naturally dictates comfort with food intake.

Allison Rankin's experience serves as a cautionary tale regarding overindulgence while on GLP-1 drugs. In 2022, three months into taking Mounjaro, Rankin, then 45, attended a large family Christmas gathering. Despite having lost 20lbs, she chose to hide her medication use. After piling her plate high with macaroni and cheese, pie, turkey, and gravy, she experienced intense nausea and the sensation of food bubbling in her throat. Due to the drugs slowing digestion, the food sat undigested in her stomach, leading her to discreetly induce vomiting in the bathroom. This episode, similar to one at Thanksgiving, highlighted the critical need for portion control on GLP-1s. Rankin, who eventually lost 50lbs on Mounjaro and Zepbound, learned from these experiences. She now eats protein-rich meals regularly, exercises, and meticulously curates her plate, spreading food out to avoid the visual cue of needing more. Having achieved her goal weight and even regained a comfortable 10lbs, Rankin is now open about her GLP-1 use, co-founding a related business, and advocating for others to understand the medication's effects and proper usage.

The experiences of Hornaman, Cole, and Rankin underscore that managing holiday meals while on GLP-1 medications or pursuing a biohacking lifestyle is a delicate balance of enjoyment and strict self-regulation. It's not about complete deprivation, but rather strategic consumption, portion control, and awareness of the body's altered responses to food, ensuring health and well-being even amidst festive temptations.